Emerging fields of fucoidan research
In addition to the significant volume of fucoidan studies in the fields of integrative oncology, gut and digestive health, immune modulation, anti-inflammation, and skincare and dermal health, fucoidans are being investigated across numerous emerging fields of research.
The following 2026 review papers provide excellent summaries of the potential of fucoidans to contribute to:
Kidney health: ‘Fucoidan: A promising natural therapeutic agent for protecting human kidney health’, published in Food Hydrocolloids for Health.
This paper explores the mechanisms by which fucoidan may support kidney health and highlights future opportunities to support chronic kidney disease.
Multidrug resistance: ‘Overcoming multidrug resistance through fucoidan from molecular mechanisms to nanomedicine applications’, published in Carbohydrate Research.
This review positions fucoidan as an apoptosis-oriented adjuvant that may contribute to re-sensitizing multidrug-resistant cancers to therapy.
Neuroregenerative health: ‘Harnessing the ocean’s power: Fucoidan as a novel neuroregenerative agent’, published in Drug Development Research.
Fucoidans have emerged as a promising class of compounds for neuronal regeneration. This paper explores the preclinical research and highlights opportunities for structure-function investigations.
Diabetes management: ‘Research progress on polyphenols and polysaccharides from marine seaweeds: Promising diabetes management natural products’, published in Marine Drugs.
Fucoidans are among the seaweed compounds identified as strong candidates for future therapies.
Pancreatic health: Polysaccharides: shining hope for future treatment of exocrine pancreatic diseases – A review’, published in the Journal of Agricultural and Food Chemistry.
This review is the first to summarise research progress on polysaccharides, including fucoidans, in relation to exocrine pancreatic diseases.